{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:17:40Z","timestamp":1788347860695,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.tracli.2006.03.016","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T10:43:11Z","timestamp":1152268991000},"page":"235-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["S\u00e9curit\u00e9 des\u00a0produits sanguins labiles et\u00a0parvovirus B19"],"prefix":"10.1016","volume":"13","author":[{"given":"J.-J.","family":"Lefr\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maniez-Montreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Defer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Laperche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2006.03.016_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0338-4535(84)80002-1","article-title":"Parvovirus (SPLV) et antig\u00e8ne Aurillac","volume":"27","author":"Courouc\u00e9","year":"1984","journal-title":"Rev. Fr. Transf. Immunoh\u00e9mat."},{"key":"10.1016\/j.tracli.2006.03.016_bib3","first-page":"117","article-title":"De la mort du flamand rose du zoo du Bronx \u00e0 l\u2019\u00e9mergence du west nile virus en transfusion sanguine","volume":"11","author":"Paulze","year":"2005","journal-title":"H\u00e9matologie"},{"key":"10.1016\/j.tracli.2006.03.016_bib4","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1128\/JVI.76.18.9124-9134.2002","article-title":"Genetic diversity within human erythroviruses: identification of three genotypes","volume":"76","author":"Servant","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.tracli.2006.03.016_bib5","first-page":"347","article-title":"Identification and characterization of a second novel human erythrovirus variant, A6","volume":"301","author":"Tri-Nguyen","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.tracli.2006.03.016_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for B19 parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tracli.2006.03.016_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.1986.tb07492.x","article-title":"A murine monoclonal IgM antibody specific for blood group P antigen (globoside)","volume":"63","author":"Von Dem Borne","year":"1986","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tracli.2006.03.016_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-0934(02)00195-7","article-title":"Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction","volume":"107","author":"Saito","year":"2003","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.tracli.2006.03.016_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(94)90993-8","article-title":"B19 parvovirus DNA in solvent\u2013detergent treated anti-hemophiliac concentrates","volume":"343","author":"Lefr\u00e8re","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(84)91126-7","article-title":"Intra-uterine parvovirus infection associated with hydrops fetalis","volume":"2","author":"Brown","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(81)91579-8","article-title":"Parvovirus infection and hypoplastic crisis in sickle cell anaemia","volume":"1","author":"Pattison","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s004300050063","article-title":"Persistent parvovirus B19 infections in immunocompromised children","volume":"186","author":"Flunker","year":"1998","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"10.1016\/j.tracli.2006.03.016_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-113-12-926","article-title":"Persistent B19 parvovirus infection type 1 (HIV-1): a treatable cause of anaemia in AIDS","volume":"113","author":"Frickhofen","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tracli.2006.03.016_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/381899","article-title":"Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and uninfected children: the women and infants transmission study","volume":"189","author":"LaMonte","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tracli.2006.03.016_bib15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(83)92152-9","article-title":"Human parvovirus. The cause of erythema infectiosum (fifth disease)?","volume":"1","author":"Anderson","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(85)91145-6","article-title":"Human parvovirus arthropathy","volume":"1","author":"White","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvovirus infection in humans","volume":"152","author":"Anderson","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tracli.2006.03.016_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/clind\/15.4.595","article-title":"Chronic parvovirus infection in a presumably immunologically healthy woman","volume":"15","author":"Faden","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tracli.2006.03.016_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1423-0410.2003.00299.x","article-title":"Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins","volume":"84","author":"Thomas","year":"2003","journal-title":"Vox Sang."},{"key":"10.1016\/j.tracli.2006.03.016_bib20","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.78.22.12169-12178.2004","article-title":"Identification and characterization of persistent human erythrovirus infection in blood donor samples","volume":"78","author":"Candotti","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.tracli.2006.03.016_bib21","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1182\/blood-2005-03-1053","article-title":"Persistent B19 infection in immunocompetent individuals. Consequences on transfusion safety","volume":"106","author":"Lefr\u00e8re","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2006.03.016_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0369-8114(02)00307-3","article-title":"Persistence of human parvovirus B19 in human tissues","volume":"50","author":"Soderlund-Venermo","year":"2002","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.tracli.2006.03.016_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/ard.54.7.597","article-title":"Persistence of parvovirus B19 in synovial fluid and bone marrow","volume":"54","author":"Nikkari","year":"1995","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.tracli.2006.03.016_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/00365549950161817","article-title":"Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow","volume":"31","author":"Lundqvist","year":"1999","journal-title":"Scand. J. Infect."},{"key":"10.1016\/j.tracli.2006.03.016_bib25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/infdis\/167.3.744","article-title":"Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence","volume":"167","author":"Foto","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tracli.2006.03.016_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A","article-title":"Evidence for persistence of human parvovirus B19 DNA in bone marrow","volume":"53","author":"Cassinotti","year":"1997","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.tracli.2006.03.016_bib27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/JCM.40.3.933-936.2002","article-title":"Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy adults","volume":"40","author":"Heegaard","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tracli.2006.03.016_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jmv.10517","article-title":"Parvovirus B19 infection in Taiwanese patients with haematological disorders","volume":"71","author":"Lee","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.tracli.2006.03.016_bib29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0369-8114(02)00302-4","article-title":"Antibody responses in parvovirus B19 infected patients","volume":"50","author":"Modrow","year":"2002","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.tracli.2006.03.016_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.tracli.2006.03.016_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(87)92006-X","article-title":"Human parvovirus infection in France 1984\u20131986","volume":"2","author":"Lefr\u00e8re","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(85)90383-6","article-title":"Familial human parvovirus infection","volume":"2","author":"Lefr\u00e8re","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0369-8114(02)00303-6","article-title":"Parvoviruses and blood products","volume":"50","author":"Laub","year":"2002","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.tracli.2006.03.016_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jcm.31.2.323-328.1993","article-title":"Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction","volume":"31","author":"McOmish","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tracli.2006.03.016_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1423-0410.1997.00001.x","article-title":"Human parvovirus B19 and blood products","volume":"72","author":"Prowse","year":"1997","journal-title":"Vox Sang."},{"key":"10.1016\/j.tracli.2006.03.016_bib36","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1046\/j.1537-2995.2001.41121500.x","article-title":"High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation","volume":"42","author":"Weimer","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.03.016_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1537-2995.2001.41010130.x","article-title":"Parvovirus B19: implications for transfusion medicine. Summary of a workshop","volume":"41","author":"Brown","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.03.016_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1423-0410.1998.7520097.x","article-title":"Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients","volume":"75","author":"Jordan","year":"1998","journal-title":"Vox Sang."},{"key":"10.1016\/j.tracli.2006.03.016_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198707303170506","article-title":"Chronic bone marrow failure due to persistent B19 parvovirus infection","volume":"317","author":"Kurtzman","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tracli.2006.03.016_bib40","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(88)90233-4","article-title":"Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia","volume":"2","author":"Kurtzman","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tracli.2006.03.016_bib42","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(87)90442-9","article-title":"Parvovirus B19 associated with foetal abnormality","volume":"1","author":"Weiland","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.03.016_bib43","unstructured":"P\u00f4le des vigilances de l\u2019EFS, communication personnelle\u00a0?."},{"key":"10.1016\/j.tracli.2006.03.016_bib44","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1537-2995.1997.37997454023.x","article-title":"Chronic anaemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion","volume":"37","author":"Cohen","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.03.016_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1537-2995.1995.35996029163.x","article-title":"Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient","volume":"35","author":"Zanella","year":"1995","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.03.016_bib46","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/j.1537-2995.2005.00610.x","article-title":"Exposure of haematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products","volume":"45","author":"Plentz","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.03.016_bib47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","article-title":"Incidence of human parvovirus B19 DNA detection in blood donors","volume":"91","author":"Yoto","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tracli.2006.03.016_bib48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s100960050406","article-title":"Occurrence and clinical role of active parvovirus infection in transplant recipients","volume":"18","author":"Galinella","year":"1999","journal-title":"Eur. J. Clin. microbial. Infect. Dis."},{"key":"10.1016\/j.tracli.2006.03.016_bib49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1034\/j.1399-0012.2000.140612.x","article-title":"Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature","volume":"14","author":"Geetha","year":"2000","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.tracli.2006.03.016_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jmv.20251","article-title":"Recurrent high level parvovirus B19\/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3","volume":"75","author":"Liefeldt","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.tracli.2006.03.016_bib51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/jcm.24.4.522-526.1986","article-title":"Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay","volume":"24","author":"Anderson","year":"1986","journal-title":"J. Clin. Microbiol."}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782006000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782006000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:27:43Z","timestamp":1761128863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782006000425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1246782006000425"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2006.03.016","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00e9curit\u00e9 des\u00a0produits sanguins labiles et\u00a0parvovirus B19","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2006.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}